Current Cardiovascular Risk Reports

, Volume 5, Issue 3, pp 215–222 | Cite as

The Combined Burden of Diabetes and Cardiovascular Disease in Indigenous Australians

Article

Abstract

Type 2 diabetes mellitus (T2DM), cardiovascular disease, and chronic kidney disease are significant contributors to the 17-year disparity in life expectancy between Indigenous and non-Indigenous Australians. These three conditions are prevalent from a young age in Indigenous Australians and clearly contribute to their premature mortality. Risk factors that both exacerbate and promote these conditions include central obesity, dyslipidemia, cigarette smoking, albuminuria, inflammation, and poor socio-economic status. Although rates of screening for T2DM are higher in Indigenous Australians than in non-Indigenous Australians, gaps in clinical management of both T2DM and cardiovascular disease exist. To enhance survival and quality of life, prevention strategies are required at a population level and from a young age in Indigenous Australians.

Keywords

Cardiovascular disease Diabetes Indigenous Australians Aboriginal Metabolic syndrome 

Notes

Acknowledgments

LMB is supported by NHMRC #605837 and the Centre of Clinical Research Excellence in Clinical Science in Diabetes, University of Melbourne. The author wished to thank Professor Kerin O’Dea for comments on this manuscript.

Disclosure

Louise Maple-Brown reports no potential conflict of interest relevant to this article.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Australian Bureau of Statistics. Population Characteristics, Aboriginal and Torres Strait Islander Australians. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/82742A1B597A338CCA257718002A6FCE?opendocument. Accessed 22 December 2010. 2006.
  2. 2.
    Australian Commonwealth Department of Health and Aged Care. Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA). http://www.health.gov.au/internet/main/publishing.nsf/Content/7B1A5FA525DD0D39CA25748200048131/$File/ocpanew14.pdf. Accessed 22 December 2010. 2001.
  3. 3.
    Heart, stroke and vascular disease: Australian facts 2004. Cardiovascular Disease Series, No. 22. 2004, Australian Institute of Health and Welfare and National Heart Foundation of Australia: Canberra.Google Scholar
  4. 4.
    O’Dea K, Patel M, Kubisch D, et al. Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. Diabetes Care. 1993;16(7):1004–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Leonard D, McDermott R, O’Dea K, et al. Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people. Aust N Z J Public Health. 2002;26(2):144–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Rowley KG, Gault A, McDermott R, et al. Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal people from a group of remote homeland communities. Diabetes Care. 2000;23(7):898–904.PubMedCrossRefGoogle Scholar
  7. 7.
    McDermott RA, Li M, Campbell SK. Incidence of type 2 diabetes in two Indigenous Australian populations: a 6-year follow-up study. Med J Aust. 2010;192(10):562–5.PubMedGoogle Scholar
  8. 8.
    O’Dea K. Westernization and non-insulin-dependent diabetes in Australian Aborigines. Ethn Dis. 1991;1(2):171–87.PubMedGoogle Scholar
  9. 9.
    Wang Z, Hoy WE. Hypertension, dyslipidemia, body mass index, diabetes and smoking status in Aboriginal Australians in a remote community. Ethn Dis. 2003;13(3):324–30.PubMedGoogle Scholar
  10. 10.
    Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6(1):1–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Harris SB, Gittelsohn J, Hanley A, et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997;20(2):185–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Ramachandran A, Snehalatha C, Latha E, et al. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997;40(2):232–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Zimmet P, Dowse G, Finch C, et al. The epidemiology and natural history of NIDDM - lessons from the South Pacific. Diabetes Metab Rev. 1990;6(2):91–124.PubMedCrossRefGoogle Scholar
  14. 14.
    Heart, stroke and vascular disease: Australian facts. Cardiovascular Disease Series, No. 14. 2001, Australian Institute of Health and Welfare, National Heart Foundation of Australia, National Stroke Foundation of Australia: Canberra. 2001.Google Scholar
  15. 15.
    Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005;182(2):66–9.PubMedGoogle Scholar
  16. 16.
    • Bradshaw PJ, Alfonso HS, Finn JC, et al.: Coronary heart disease events in Aboriginal Australians: incidence in an urban population. Med J Aust 2009, 190(10): 583–6. This study provides important longitudinal data on coronary heart disease events in urban Indigenous Australians. PubMedGoogle Scholar
  17. 17.
    • Vos T, Barker B, Begg S, et al.: Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol 2009, 38(2): 470–7. This study uses the burden of disease approach to identify contributors to the health gap between Indigenous and non-Indigenous Australians. The important findings are the significant impact of chronic conditions such as diabetes and cardiovascular disease, and the disproportionate burden of disease in remote (compared to urban) Indigenous Australians. PubMedCrossRefGoogle Scholar
  18. 18.
    • Brown A, Brieger D, Tonkin A, et al.: Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference. Heart Lung Circ 2010, 19(5–6): 299–305. This is an excellent summary of the background and current issues related to coronary disease in Indigenous Australians. PubMedCrossRefGoogle Scholar
  19. 19.
    Gault A, O’Dea K, Rowley KG, et al. Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia. Diabetes Care. 1996;19(11):1269–73.PubMedCrossRefGoogle Scholar
  20. 20.
    McDonald SP, Wang Z, Hoy WE. Physical and biochemical predictors of death in an Australian aboriginal cohort. Clin Exp Pharmacol Physiol. 1999;26(8):618–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Thompson PL, Bradshaw PJ, Veroni M, Wilkes ET. Cardiovascular risk among urban Aboriginal people. Med J Aust. 2003;179(3):143–6.PubMedGoogle Scholar
  22. 22.
    McDonald SP, Maguire GP, Hoy WE. Validation of self-reported cigarette smoking in a remote Australian Aboriginal community. Aust N Z J Public Health. 2003;27(1):57–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Health Survey 2004–2005. 2006, Canberra.Google Scholar
  24. 24.
    McDermott R, Rowley KG, Lee AJ, et al. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian aboriginal community. Med J Aust. 2000;172(10):480–4.PubMedGoogle Scholar
  25. 25.
    Rowley KG, Daniel M, Skinner K, et al. Effectiveness of a community-directed ‘healthy lifestyle’ program in a remote Australian aboriginal community. Aust N Z J Public Health. 2000;24(2):136–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Li M, Campbell S, McDermott RA. Six year weight change and type 2 diabetes among Australian Indigenous adults. Diabetes Res Clin Pract. 2010;88(2):203–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Daniel M, Rowley KG, McDermott R, et al. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care. 1999;22(12):1993–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Piers LS, Rowley KG, Soares MJ, O’Dea K. Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry. Eur J Clin Nutr. 2003;57(8):956–63.PubMedCrossRefGoogle Scholar
  29. 29.
    Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. The Lancet. 2005;366(9497):1640–9.CrossRefGoogle Scholar
  30. 30.
    • O’Dea K, Cunningham J, Maple-Brown L, et al. Diabetes and cardiovascular risk factors in urban Indigenous adults: results from the DRUID study. Diabetes Res Clin Pract. 2008;80(3):483–9. This study is the largest comprehensive study of urban Indigenous Australians, important as 76% of Indigenous Australians live in the urban setting but the majority of research has been conducted in regional and remote settings. The index of obesity most closely associated with diabetes in this cross-sectional study was waist-to-hip ratio. PubMedCrossRefGoogle Scholar
  31. 31.
    Li M, McDermott RA. Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res Clin Pract. 2010;87(3):401–6.PubMedCrossRefGoogle Scholar
  32. 32.
    • O’Neal DN, Piers LS, Iser DM, et al. Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis. 2008;201(2):368–77. This study describes the marked lipid abnormalities commonly seen in Indigenous Australians: dyslipidaemia including high triglycerides, low HDL and small LDL. PubMedCrossRefGoogle Scholar
  33. 33.
    O’Dea K, Lion RJ, Lee A, et al. Diabetes, hyperinsulinemia, and hyperlipidemia in small aboriginal community in northern Australia. Diabetes Care. 1990;13(8):830–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.PubMedCrossRefGoogle Scholar
  35. 35.
    Wang Z, Hoy WE. Albuminuria and incident coronary heart disease in Australian Aboriginal people. Kidney Int. 2005;68(3):1289–93.PubMedCrossRefGoogle Scholar
  36. 36.
    Rowley KG, Iser DM, Best JD, et al. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia. 2000;43(11):1397–403.PubMedCrossRefGoogle Scholar
  37. 37.
    Rowley K, Walker KZ, Cohen J, et al. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust. 2003;178(10):495–500.PubMedGoogle Scholar
  38. 38.
    Shemesh T, Rowley KG, Jenkins A, et al. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. Int J Obes (Lond). 2007;31(1):103–8.CrossRefGoogle Scholar
  39. 39.
    • Wang Z and Hoy WE: C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Aust N Z J Public Health 2010, 34 Suppl 1: S25-9. This study higlights the important independent contribution of non-traditional CVD risk factors such as CRP to CVD cases among Indigenous Australians. PubMedCrossRefGoogle Scholar
  40. 40.
    Maple-Brown LJ, Cunningham J, Celermajer DS, O’Dea K. Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clin Endocrinology. 2007;66:419–25.CrossRefGoogle Scholar
  41. 41.
    Cunningham J, O’Dea K, Dunbar T, et al. Socioeconomic status and diabetes among urban Indigenous Australians aged 15–64 years in the DRUID study. Ethn Health. 2008;13(1):23–37.PubMedCrossRefGoogle Scholar
  42. 42.
    Cass A, Cunningham J, Wang Z, Hoy W. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust. 2001;175(1):24–7.PubMedGoogle Scholar
  43. 43.
    Cass A, Cunningham J, Snelling P, et al. End-stage renal disease in indigenous Australians: a disease of disadvantage. Ethn Dis. 2002;12(3):373–8.PubMedGoogle Scholar
  44. 44.
    Falhammar H, Davis B, Bond D, Sinha AK. Maternal and neonatal outcomes in the Torres Strait Islands with a sixfold increase in type 2 diabetes in pregnancy over six years. Aust N Z J Obstet Gynaecol. 2010;50(2):120–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med. 2000;9(1):83–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Bunt JC, Tataranni PA, Salbe AD. Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children. J Clin Endocrinol Metab. 2005;90(6):3225–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care. 1998;21 Suppl 2:B138–41.PubMedGoogle Scholar
  48. 48.
    Young TK, Martens PJ, Taback SP, et al. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native canadians. Arch Pediatr Adolesc Med. 2002;156(7):651–5.PubMedGoogle Scholar
  49. 49.
    Zhao Y, Connors C, Wright J, et al. Estimating chronic disease prevalence among the remote Aboriginal population of the Northern Territory using multiple data sources. Aust N Z J Public Health. 2008;32(4):307–13.PubMedCrossRefGoogle Scholar
  50. 50.
    ANZDATA Registry Report, S. McDonald, L. Excell, and B. Livingston, Editors. 2009, Australia and New Zealand Dialysis and Transplant Registry: Adelaide.Google Scholar
  51. 51.
    Hoy WE, Kincaid-Smith P, Hughson MD, et al. CKD in Aboriginal Australians. Am J Kidney Dis. 2010;56(5):983–93.PubMedCrossRefGoogle Scholar
  52. 52.
    Wang Z, Hoy WE. Association between diabetes and coronary heart disease in Aboriginal people: are women disadvantaged? Med J Aust. 2004;180(10):508–11.PubMedGoogle Scholar
  53. 53.
    Hu G, Jousilahti P, Qiao Q, et al. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol. 2005;45(9):1413–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Maple-Brown LJ, Brimblecombe J, Chisholm D, O’Dea K. Diabetes care and complications in a remote primary health care setting. Diabetes Res Clin Pract. 2004;64(2):77–83.PubMedCrossRefGoogle Scholar
  55. 55.
    Maple-Brown L, Cunningham J, Dunne K, et al. Complications of diabetes in urban Indigenous Australians: the DRUID study. Diabetes Res Clin Pract. 2008;80(3):455–62.PubMedCrossRefGoogle Scholar
  56. 56.
    Si D, Bailie R, Dowden M, et al. Assessing quality of diabetes care and its variation in Aboriginal community health centres in Australia. Diabetes Metab Res Rev. 2010;26(6):464–73.PubMedCrossRefGoogle Scholar
  57. 57.
    National Heart Foundation of Australia. Guidelines for the assessment of absolute cardiovascular disease risk 2009. Available at http://www.heartfoundation.org.au/SiteCollectionDocuments/A_AR_Guidelines_FINAL%20FOR%20WEB.pdf . Accessed January 5, 2011.
  58. 58.
    Central Australian Rural Practitioners Association. CARPA standard treatment manual. 5th ed. Alice Springs: CARPA; 2009.Google Scholar
  59. 59.
    Peiris DP, Patel AA, Cass A, et al. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust. 2009;191(6):304–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Menzies School of Health ResearchCharles Darwin UniversityCasuarinaAustralia
  2. 2.Division of MedicineRoyal Darwin HospitalDarwinAustralia

Personalised recommendations